Beijing University Pharmaceutical: Initiating Name Change for the Company and Affiliated Subsidiaries, Marking 'Separation from Peking University'
2 week ago / Read about 0 minute
Author:小编   

On August 8, Beijing University Pharmaceutical announced that the proposal for a name change was approved at the 12th meeting of the 11th Board of Directors. Given that the company's de facto controller has been transitioned to Xu Xiren and there is no longer any equity tie with Peking University, the decision to change the company's name aims to clarify the ownership structure and align with business growth objectives, thus marking a 'separation from Peking University'.